Suven Life Sciences Ltd Share Price

AGM Date: 06 Aug 2021

Suven Life Sciences Ltd has informed BSE about Outcome of Board Meeting held on May 04, 2021. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 04th August, 2021 to 06th August, 2021 (both days inclusive) for taking record of the Members of the Company for the purpose of 32nd Annual General Meeting of the Company. With reference to the above subject, pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 32nd Annual General Meeting of the Members of the Company and the Annual Report for the Financial Year 2020-21 which is simultaneously circulated to the shareholders through electronic mode. The 32nd Annual General Meeting will be held on Friday, August 06th, 2021 at 11:30 a.m. IST, through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: http://www.suven.com/annualreports.aspx. This is for your information and record. (As Per BSE Announcement dated on 12.07.2021) This is with reference to our earlier letter dated 12th July, 2021 regarding the 32nd Annual General Meeting (AGM) of the Company held today i.e. Friday, 06th August, 2021 and the business mentioned in the Notice dated 04th May, 2021 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record. Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 6/8/2021)

AGM Date: 04 Aug 2022

Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 02nd August, 2022 to 04th August, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of 33rd Annual General Meeting of the Company. e-Annual General Meeting (AGM): The 33rd Annual General Meeting of the Company will be held on Thursday, the 04th day of August, 2022 through VC/OAVM. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 02nd August, 2022 to 04th August, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of 33rd Annual General Meeting of the Company. (As Per BSE Announcement Dated on 10.05.2022) With reference to above subject, pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the copies of the newspaper advertisements as appeared on 05th July, 2022 in Nava Telangana (Telugu) and Business Standard (English). The above information will also be hosted on the website of the Company at: http://www.suven.com/agm.aspx (As Per BSE Announcement Dated on 05/07/2022) Pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the Notice of the 33rd Annual General Meeting of the Members of the Company and the Annual Report for the Financial Year 2021-22 which is simultaneously circulated to the shareholders through electronic mode. The 33rd Annual General Meeting will be held on Thursday, August 04th, 2022 at 11:30 a.m. IST, through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: http://www.suven.com/annualreports.aspx. (As per BSE Announcement Dated on 11/07/2022) This is with reference to our earlier letter dated 11th July, 2022 regarding the 33rd Annual General Meeting (AGM) of the Company held today i.e. Thursday, 04th August, 2022 and the business mentioned in the Notice dated 24th June, 2022 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated 04.08.2022)

AGM Date: 05 Aug 2023

With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. May 09, 2023, approved the following along with other business matters. Took on record and approved the Audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and Financial Year ended 31st March, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Audit Reports of the Statutory Auditors. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 03rd August, 2023 to 05th August, 2023 (both days inclusive) for taking record of the Members of the Company for the purpose of 34th Annual General Meeting of the Company. News Paper Advertisement - Information regarding the 34th Annual General Meeting to be held through video conference (VC)/ other Audio Visual Means (OVAM). (As Per BSE Announcement Dated on 07.07.2023) please find enclosed herewith the Notice of the 34th Annual General Meeting of the Members of the Company and the Annual Report for the Financial Year 2022-23 which is simultaneously circulated to the shareholders through electronic mode. The 34th Annual General Meeting will be held on Saturday, August 05th, 2023 at 11:30 a.m. IST, through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: http://www.suven.com/annualreports.aspx. News Paper Advertisement regarding Notice of 34th Annual General Meeting of the company, Book Closure and E-Voting information (As per BSE Announcement Dated on 11/07/2023) Outcome of the 34th Annual General Meeting held on 05th August 2023. (As Per BSE Announcement dated on 05.08.2023)

AGM Date: 02 Aug 2024

Annual General Meeting & Closure of Register of Members & Share Transfer Books Outcome of 35th Annual General Meeting held on 02nd August, 2024 (As Per BSE Announcement dated on 02.08.2024)

AGM Date: 22 Aug 2025

Outcome of the Meeting of Board of Directors of Suven Life Sciences Limited held on Tuesday, May 13, 2025 Notice of 36th Annual General Meeting (As Per BSE Announcement Dated on :30.07.2025) 36th Annual General Meeting was held on 22nd August, 2025, summary of proceedings enclosed. (As per BSE Announcement Dated on 22/08/2025)

EGM Date: 20 Mar 2021

Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended and other applicable provisions of law, we wish to inform you that the Board of Directors of the company at its meeting held today i.e. 20th February, 2021 has inter-alia considered and approved the following: 1. Issuance of 1,81,00,000 (One Crore Eighty-One Lakh) fully Convertible Warrants on Preferential Basis to the Promoter/ Promoter Group (details as annexed) of the company in accordance with the provisions of the Companies Act, 2013, Chapter V of the SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable statutory provisions and subject to the approval of shareholders in the Extra-Ordinary General Meeting of the Company; Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 and other applicable provisions of law, please find enclosed the Notice of Extra-Ordinary General Meeting (EGM) of Suven Life Sciences Limited ('the Company') to be held on Saturday, 20th March, 2021 at 11.30 a.m. (IST) through video conference ('VC') / other audio-visual means ('OAVM'). The Notice of EGM has been dispatched electronically to the members whose email IDs are registered with the Company/ Depositories. The Notice of EGM is also uploaded on the Company's website at www.suven.com. This is for your information and record. (As Per BSE Announcement dated on 25.02.2021) This is with reference to our earlier letter dated 25th February, 2021 regarding the Extra-Ordinary General Meeting (EGM) of the Company held today i.e. Saturday, 20th March, 2021 and the business mentioned in the Notice dated February 20, 2021 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record. (As Per BSE Announcement dated on 20.03.2021) Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 21.03.2021) With reference to the subject matter, we wish to inform you that in terms of the special resolution passed by the Members of the Company at its Extra-Ordinary General Meeting held on 20th March, 2021 and in accordance with the 'In-principle approval' granted by the NSE and BSE, the Board of Directors of the Company in its meeting held today i.e. 02nd April, 2021 has allotted 1,81,00,000 (One crore eighty one lakh) Warrants convertible into Equity Shares to Jasti Property and Equity Holdings Private Limited (In its capacity as sole trustee of Jasti Family Trust), promoter group entity at an issue price of Rs. 81.57/- per Warrant on preferential basis in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. (As Per BSE Announcement Dated on 02.04.2021)

EGM Date: 05 Jun 2025

Outcome of the Meeting of Board of Directors of Suven Life Sciences Limited held on Tuesday, May 13, 2025 Notice of Extra-ordinary General Meeting to be held on Thursday, June 5, 2025 (As Per BSE Announcement Dated on: 14/05/2025) Corrigendum to Notice of the Extra-Ordinary General Meeting to be held on 05th June, 2025 (As Per BSE Announcement Dated on: 28/05/2025) Outcome of the EGM held on 05th June, 2025 (As Per BSE Announcement Dated on: 05.06.2025)